Fosamax Fracture Lawsuits Dismissed Again, After Judge Rules FDA Rejected Label Warning Change
The FDA rejected an effort by Merck to add new Fosamax fracture label warnings in 2009, a federal judge determined.
The FDA rejected an effort by Merck to add new Fosamax fracture label warnings in 2009, a federal judge determined.
Both Fosamax and Actonel had similar risks of patient suffering hip fractures following a two year drug holiday, but longer holidays increased the risk of Actonel fractures, researchers found.